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Background: Medication non-adherence has a dynamic, temporal and multifactorial
nature with a significant impact on economic and clinical outcomes. Interventions to
improve adherence are complex and require adaptation to patients’ needs, which may
include patient’s medical conditions. The aim of this study was to assess the comparative
effectiveness of medication adherence interventions per type of clinical condition on adult
patients.
Methods: A systematic review with network meta-analysis was performed (PROSPERO
registration number of CRD42018054598). An initial Pubmed search was conducted
to select meta-analyses reporting results of interventions aiming to improve medication
adherence. Primary studies were selected and those reporting results with a long-term
follow up (≥10 months) on adult patients were included for data extraction. Study
characteristics, description of interventions and adherence outcomes were extracted.
Adherence interventions were classified in four groups: educational, attitudinal, technical,
and rewards. Clinical conditions were classified in four groups: circulatory system
and metabolic diseases, infectious diseases, musculoskeletal diseases, and mental,
behavioral or neurodevelopmental disorders. Network meta-analyses with effect sizes
expressed as odds ratio (OR) with a 95% credibility interval (CrI) were built. Ranking
probabilities for each measure of adherence were calculated by using surface under the
cumulative ranking analysis (SUCRA).
Results: A total of 61 meta-analysis and 149 primary studies were included in the
qualitative synthesis and 80 primary studies in the quantitative analysis. The most
effective interventions were: educational + technical 79.6% [OR: 0.44 (CrI: 0.26, 0.73)]
and 73.3% [OR: 0.56 (0.36, 0.84)] in circulatory system and metabolic diseases and
infectious diseases respectively. Attitudinal intervention had the greatest probability
for musculoskeletal diseases of 92.3% in SUCRA [OR: 0.30 (0.10, 0.86)]. Finally,
educational+ attitudinal interventions had the greatest effect (SUCRA 73.8%) for mental,
behavioral or neurodevelopmental disorders, although this was not significant according
to consistency analysis.
Torres-Robles et al. Interventions to Improve Medication Adherence
Conclusion: Effectiveness of interventions seems to be related to the clinical
condition. Educational and technical interventions resulted in a major effect on long-term
management of medication adherence in patients with infectious diseases (HIV) and
circulatory system and metabolic diseases whereas attitudinal components presented
a higher effect on musculoskeletal and mental, behavioral or neurodevelopmental
disorders.
Keywords: medication adherence, network meta-analysis, chronic diseases, long-term, intervention, adherence
implementation
INTRODUCTION
Medication non-adherence represents a continuous burden
for the health-care system. Statistics remain constant since
2003, when the World Health Organization reported at
least 50% of patients with chronic conditions were non-
adherent to their medications (Sabate, 2003). Non-adherence
can occur at different stages during the course of therapy,
including initiation, implementation and persistence
(Vrijens et al., 2012). A study analyzing an electronic
database of nearly 17,000 patients’ dosing histories across
different diseases states for 1 year (including osteoporosis,
diabetes, hypertension, depression and HIV), revealed
4% patients never initiated their treatment, nearly 40%
discontinued, and only 55% dosed correctly (Blaschke et al.,
2012).
The negative consequences of this phenomenon have been
widely reported in the literature. For example, a recent systematic
review found the economic impact of non-adherence, including
the healthcare costs, ranged from $949 to $44,190 per patient
annually across 14 disease groups (Cutler et al., 2018).
During the past 10 years there has been mounting evidence
demonstrating the impact of diverse interventions onmedication
adherence in a range of clinical outcomes (Nieuwlaat et al.,
2014). Effective adherence interventions have resulted in viral
suppression in HIV patients (Mills et al., 2014), decrease
of lipid levels and total cholesterol in patients taking lipid
lowering medications (Deichmann et al., 2016), reduction
of HbAc1, decrease hospitalizations and all-cause mortality
in patients with diabetes (Ho et al., 2006), and reduction
of risk of death and hospitalizations in patients with heart
failure (Fitzgerald et al., 2011). Despite their proven efficacy,
there is still a lack of consistent evidence on the core
elements these interventions should include, limiting their
implementation in routine practice. Effective interventions
appear to be complex (through a combination of multiple core
components) and tailored to the patient’s needs (Nieuwlaat
et al., 2014; Conn et al., 2016). Different intervention’s success
may be linked to the clinical condition being targeted. For
example, there is some evidence technical interventions are
effective in patients with hypertension (Conn et al., 2015),
whereas interventions aiming to modify patients’ beliefs and
attitudes have been found to be more effective in patients with
mental disorders (MacDonald et al., 2016; Readdean et al.,
2018).
Heterogeneity of interventions and adherence measures is
often reported to be a barrier for the quantitative analysis of
interventions, hindering the comparison across different studies
(Nieuwlaat et al., 2014). Some meta-analyses have overcome
this limitation by directly comparing the effect of interventions
on a range of adherence measures (Conn and Ruppar, 2017).
However, these analyses lack indirect comparisons that could
strengthen the current evidence. The use of network meta-
analysis provides an advantage when compared to traditional
meta-analysis methods, as it allows a comparison of multiple
treatments or interventions at the same time, using both direct
comparisons within randomized controlled trials and indirect
comparisons across trials based on a common comparator
(Tonin et al., 2017). Currently, a few network meta-analyses
have been undertaken with the objective of assessing the impact
of adherence interventions in HIV patients (Mills et al., 2014;
Kanters et al., 2017).
Thus, the aim of this systematic review and network meta-
analysis was to assess the comparative effectiveness of medication
adherence interventions per type of clinical condition on adult
patients being prescribedmedications for the following condition
groups: circulatory system and metabolic diseases, infectious
diseases, musculoskeletal diseases, and mental, behavioral or
neurodevelopmental disorders.
METHODS
As part of a larger project, this systematic review and
network meta-analysis was performed following the Cochrane
recommendations (Higgins JPT, 2011) and PRISMA statement
for reporting systematic reviews incorporating network meta-
analyses (Hutton et al., 2015) on health care interventions
(PROSPERO registration number of CRD42018054598).
Search Strategy and Eligibility Criteria
To avoid inefficient duplication of efforts in a field like
medication adherence with a vast body of primary and secondary
literature, a two-steps approach was used for literature selection
(Nieuwlaat et al., 2014). The first step aimed to retrieve pairwise
meta-analyses assessing interventions to improve medication
adherence on adult patients. In a second step, primary
articles identified in the meta-analyses reporting experimental
controlled trials were identified as data sources for our
study.
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The meta-analyses were systematically searched in PubMed,
which comprises Medline and PubMed Central, in October
2017 with no restriction on publication date or language. A
first screening by title and abstract of the meta-analyses was
performed by two independent investigators and discrepancies
were solved by a third reviewer. The search strategy can be found
on the Supplementary Material 1.
In the second step, primary studies were selected from the
identified meta-analyses and were full-text reviewed by two
investigators. Primary studies with an experimental controlled
design (randomized or non-randomized clinical trials) assessing
the long-term effect of adherence interventions (follow-up of
more than 10 months) and reporting measures of adherence
(i.e., self-repot, pill count, refill data, electronic monitoring)
on adult patients with prescribed medications were included
for data extraction. Studies were excluded if the interventions
were not patient-focused, assessed adherence to the following
medications (over the counter medications, depot medications,
vaccines), were not written in Roman characters, or were
unpublished studies (e.g., conference posters, dissertations).
From the eligible studies, those reporting adherence results
as a categorical variable were included in the network
meta-analysis. Studies reporting continuous data were only
considered for qualitative analysis. Other studies not included
in the network meta-analysis were those with the same
intervention in all the study arms (same comparator) and
clinical conditions without a sufficient number of studies
to perform a comparative analysis. Additional information
regarding inclusion or exclusion criteria can be found in
Supplementary Material 2.
Data Extraction and Quality Assessment
Data from primary studies was extracted by two investigators
and recorded on a standard data collection form. This
included: authors, year of publication, country, sample size,
clinical condition being targeted, sex, age, patient follow up
period, study arms, interventions assessed, and measures of
adherence. Targeted diseases were identified for each study
and then classified in groups based on the International
Classification of Diseases 11th Revision (ICD-11) (World
Health Organization, 2018) into circulatory system and
metabolic diseases, infectious diseases, musculoskeletal
diseases, and mental, behavioral or neurodevelopmental
disorders as described in Table 1. Circulatory system and
metabolic diseases were classified as one group as they share
common risk factors and patients are usually prescribed
with medications from both groups (Cheung and Li,
2012).
An overall composite score was defined for each study, as
the proportion of adherent patients reported by any measure.
If a study had more than one method of assessment, a mean
adherence rate was calculated. The validation of this score has
been previously described elsewhere (Tonin et al., 2018).
For optimal comparison and interpretation of the
results, adherence interventions were classified into four
categories: attitudinal, rewards, educational, and technical
based on previous definitions (Roter et al., 1998; Demonceau
TABLE 1 | Definition of groups for classification of clinical conditions.
Disease group Clinical conditions included
Circulatory system and
metabolic diseases
Hypertension, Coronary disease, Diabetes,
Heart Failure, Stroke, Dyslipidaemia,
Hyperlipidaemia, Diabetes
Infectious diseases HIV
Musculoskeletal diseases Osteoporosis, osteoarthritis
Mental, behavioral or
neurodevelopmental disorders
Schizophrenia, bipolar disorder, psychosis,
depression, tobacco dependence
et al., 2013; Sapkota et al., 2015). Usual care was defined
as standard of care (SOC) for this analysis. Included
studies could have a single component or combination
of multiple components comprising their intervention.
The definitions for the interventions can be found in
Supplementary Material 3.
Risk of bias assessment was undertaken for all the primary
studies included in the analysis. It was performed by two
investigators using the Cochranene collaboration risk of bias
Assessment tool (RoB) (Higgins et al., 2011).
Data Analysis
A network meta-analysis using Bayesian framework was
performed to compare the effectiveness of reported interventions
on adherence rates of long-term interventions (with a follow-up
of more than 10 months) across the condition groups previously
described. This analysis was based on the Markov Chain
Monte Carlo simulation. Transitivity analyses were performed by
comparing population, interventions, and outcome definitions
among the included studies. To analyse the multiple-arms
studies a common heterogeneity parameter was considered and
a conservative analysis of non-informative priors was conducted
(Dias et al., 2010; Rucker et al., 2017).
Effect sizes measures were expressed as odds ratio (OR) with
a 95% credibility interval (CrI). The goodness of fit of the
model and consistency were assessed using the lowest residual
deviance information criteria (DIC) between fixed and random-
effect models tested. Convergence was attained based on visual
inspection of Brooks-Gelman-Rubin plots and potential scale
reduction factor-PSRF (1 < PSRF ≤ 1.05) (Dias et al., 2010;
Higgins et al., 2012).
Ranking probabilities for each measure of adherence were
calculated by using surface under the cumulative ranking analysis
(SUCRA) to increase the estimate precision of the relative effect
sizes of comparisons and to properly account for correlations
between multi-arm trials (Mbuagbaw et al., 2017). SUCRA values
can range from 0% (i.e., the intervention always ranks last) to
100% (it always ranks first).
Robustness of the network when having close-loops, was
assessed via node-splitting analysis (p < 0.05 reveal significant
inconsistencies in the network) (van Valkenhoef et al., 2016).
Sensitivity analyses with the hypothetical removal or inclusion of
the studies were conducted when discrepancies were identified in
the network. All analyses were performed using software Addis
version 1.17.6 (van Valkenhoef et al., 2013).
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RESULTS
A total of 920 records were identified and 61 meta-analyses,
which included a median of 17.0 studies each [IQR 10.5–
28.5; range 2–101], were finally selected for extraction of
primary studies. From the selected meta-analyses, 1,119
primary studies were identified and 689 were assessed full-
text for eligibility with 150 being included in the qualitative
analysis and 80 in the network meta-analysis (Figure 1; and
Supplementary Material 4). For those studies included in the
qualitative synthesis, the publication years ranged between 1979
and 2016, with a median of 2007 (IQR 2006–2012). The number
of studies per disease group was: 38 focused on infectious
diseases (25.5%), 62 on circulatory system and metabolic diseases
(41.6%), 13 on mental, behavioral or neurodevelopmental
disorders (8.7%) and 14 on musculoskeletal diseases (9.4%). Five
studies (3.4%) reported results in two groups of diseases and
the remaining 16 studies (10.7%) corresponded to respiratory,
FIGURE 1 | Flowchart of systematic review and network meta-analysis process.
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digestive, transplant and undefined conditions. The only
available articles classified into infectious diseases were focused
on HIV (Human Immunodeficiency Virus).
Overall, 178,229 patients were included in the analyses, with
the following distribution across disease groups: circulatory
system and metabolic diseases (n = 59,959), infectious diseases
(HIV) (n = 18,737), musculoskeletal diseases (n = 72,595)
and mental, behavioral or neurodevelopmental disorders (n
= 2,632). The average follow-up time was 14 months with
the majority reporting a follow-up of 12 months (n = 115
studies). The most common interventions were educational
(n = 49 studies, 28%), followed by educational + technical
(n = 41, 23%), technical (n = 36, 20%), educational +
attitudinal (n = 20, 11%), attitudinal (n = 21, 12%), educational
+ attitudinal + technical (n = 5, 3%) and only 3 studies
(1.7%) containing the rewards component (rewards, rewards
+ technical, educational + attitudinal + rewards). In 134
studies (89.3%), standard care was used as a common
comparator.
The risk of bias analysis resulted in a low risk on selective
reporting (n = 146 studies, 98%) as all the papers reported the
expected adherence outcomes. Around 20% of studies presented
a high risk of bias for incomplete outcome data domain (n =
34) due to the lack of intention-to-treat analysis or missing data.
Allocation concealment was classified as unclear risk of bias in
most of the studies (n= 121, 81.2%). Additional information can
be found in the Supplementary Material 5.
In the quantitative analysis, 80 studies were included, with 69
excluded due to the following reasons: (1) categorical medication
adherence data not reported (n = 57), (2) same intervention
category in all study arms (n = 3); and (3) not enough studies
to be categorized and analyzed by disease group (n= 9).
Network meta-analyses were conducted per disease
group (Figure 2), as described below. The list of included
studies for each network meta-analysis can be found in
Supplementary Material 6. Networks were found to be robust,
with no significant inconsistency (Table 2 consistency analysis
and Supplementary Material 7).
Circulatory System and Metabolic
Diseases
Thirty-one studies were included in this network, with seven
different interventions being compared. Three studies assessed
a combination of multiple intervention types, with a majority
comparing educational+ technical interventions (n=12 studies)
and educational interventions (n= 11) vs. SOC.
Educational + technical interventions were more effective
in improving adherence when compared to SOC [OR: 0.44
(CrI: 0.26, 0.73)] (Table 2). In terms of ranking probabilities
(SUCRA analysis), educational+ technical interventions had the
FIGURE 2 | Networks diagrams of interventions on adherence across disease groups. Each line represents a direct comparison of interventions and the number of
studies reporting that comparison is written on each line. From left to right: (A) Circulatory system and metabolic diseases, (B) Infectious diseases (HIV), (C)
Musculoskeletal diseases, (D) Mental, behavioral or neurodevelopmental disorders.
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highest probability of being the best intervention at improving
adherence in this disease group (79.6%). Technical interventions
were ranked second (71.6%) and educational interventions third
(55.9%). SOC ranked last (19.4%).
Infectious Diseases: HIV
A total of 32 studies were included in this network with
6 different interventions. Three of these interventions were
multicomponent. The majority of studies compared technical (n
= 11) or educational+ technical (n= 7) against SOC.
There were significant differences favoring educational +
technical interventions [OR: 0.56 (0.36, 0.84)] and technical
interventions [OR: 1.63 (1.16, 2.38)] compared to SOC (Table 2).
SUCRA analysis showed educational + technical as the most
probable to enhance adherence with a likelihood of 73.7%,
followed by technical (63.2%) and educational + attitudinal
(61.0%). Again, SOC ranked last (8.5%).
Musculoskeletal Diseases
A total of 11 studies with 4 intervention combinations
were analyzed in this network. The educational + technical
interventions were used in 7 studies and were compared
to SOC. Consistency analysis revealed statistical differences
between attitudinal [OR: 0.30 (0.10, 0.86)], educational [OR: 0.37
(0.14, 0.91)] and technical [OR: 1.60 (1.26, 1.98)] interventions
compared to SOC (Table 2).
Attitudinal interventions had the greatest probability of
being the best option (92.3%) when compared to the other
interventions. Educational (74.0%) and technical (48.3%)
interventions ranked second and third, respectively. The lowest
effect was for SOC (14.8%).
Mental, Behavioral, or
Neurodevelopmental Disorders Diseases
This network was comprised of 10 studies and compared 2 single
component interventions, 2 combination interventions and
standard care. Three studies assessed attitudinal interventions
and three evaluated educational interventions. Two included
educational + technical interventions and another two
studies assessed educational + attitudinal interventions. All
interventions were compared to SOC. No significant differences
were found between types of interventions for this disease group
(Table 2).
According to the SUCRA analysis, educational +
attitudinal interventions ranked first (73.8%). Second
and third rankings consisted of educational (72.5%) and
attitudinal (65.3%) interventions respectively (See SUCRAS in
Supplementary Material 8).
DISCUSSION
To the best of our knowledge, this is the first network meta-
analysis assessing the comparative effectiveness of interventions
aimed at improving medication adherence to chronic
medications across different disease groups, with long-term
follow-up periods. Differences in the effects of the interventions
were found by disease groups, suggesting that adherence
interventions should be adapted to the condition being
targeted. There are numerous condition-related determinants
affecting medication adherence (e.g., presence of symptoms,
disease severity, clinical improvement, duration of the disease,
psychiatric conditions) that require tailored and multifaceted
approaches (Kardas et al., 2013).
Adherence interventions in circulatory system and metabolic
diseases and infectious diseases (HIV) were significantly more
effective when combining educational + technical components
(with SUCRA values between 70 and 80%). Interventions
involving educational components only (i.e., interventions
providing information regarding the medication, disease state or
importance of adherence with the aim of increasing a patient’s
knowledge or skills that facilitate adherence) are one of the most
frequent strategies used in health care to change patient behavior
(Sapkota et al., 2015). As hypothesized by the Information-
Motivation-Strategy model (IMS) (DiMatteo et al., 2012),
“patients are only capable of doing what they clearly understand,”
emphasizing the importance of adequate patient information and
knowledge to follow a treatment regimen (DiMatteo et al., 2012).
However, the effectiveness of information provision and its effect
on medication adherence can be affected by a range of healthcare
team and system-related factors, such as poor patient-physician
communication, patient’s lack of trust, lack of shared decision
making or poor follow-up amongst others (Kardas et al., 2013).
Moreover, there is evidence a high proportion of patients are
unable to remember the information provided during a medical
consultation, highlighting that although essential, the provision
of information as an isolated strategy can be insufficient to ensure
medication adherence (Kravitz et al., 1993). Also suggested by
the IMS model, patients can be non-adherent if they lack a
strategy that allows them to follow their health care provider’s
recommendations (DiMatteo et al., 2012), as found especially
evident in unintentional non-adherence (Horne et al., 2005).
Patients must have the strategies and resources to be able to
overcome practical barriers faced when attempting to follow
their health care provider’s recommendations (DiMatteo et al.,
2012). Therefore, adding the use of technical components, that
is interventions providing any gadget, instrument, or system
that facilitate medication intake or increase convenience of the
medication taking process, may increase medication adherence.
These interventions often help patients adopt routines of
medication taking when they have memory problems or have
busy social lives that limit their ability to be adherent (Vervloet
et al., 2012).
The results obtained for circulatory system and metabolic
diseases and infectious diseases (HIV) are in agreement with
previous literature reporting an increased effect when combining
different interventions components (Kanters et al., 2017). A
more specific analysis conducted in Africa revealed that adding
educational and technical components to standard care could
improve medication adherence (Mills et al., 2014). Other
technical components such as regimen simplification, available
for some of the medications used for HIV treatment, resulted
in an increase on adherence as it reduces pill burden (Parienti
et al., 2009; Nachega et al., 2014). There is also a reduction
in treatment complexity and polypharmacy, important barriers
preventing patients to adhere to their medications (Marcum and
Gellad, 2012). Additionally, patients have to integrate doses into
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daily life, a process that may sometime represent shame or fear
associated with the condition stigma. Minimizing this process
may also reduce burden (Katz et al., 2013).
Attitudinal interventions were found to have the best effect
to increase medication adherence in patients suffering from
musculoskeletal diseases, with a SUCRA of 99.25% and were
found to be significantly different to standard care. These findings
indicate there is a strong effect from the use of behavior change
theories on the improvement of medication adherence on these
diseases. This might be due to a higher prevalence of intentional
non-adherence (Horne and Weinman, 1999) in patients with
these conditions. The Health Belief Model suggests that a
health behavior can be influenced by perceived susceptibility,
severity, benefits and barriers regarding a disease or condition
(Glanz et al., 2015) and it has been suggested that effective
relationships between physician and patients are necessary in
order to help them to cope with medication non-adherence
problems (DiMatteo et al., 2007). Therefore, behavior based
theories that can be provided by physicians, such as motivational
interviewing, can be used to improve adherence (Easthall et al.,
2013). These often consist of focused skills to help the patient
solve ambivalence and find solutions (Miller and Rollnick, 2012).
Consistency analysis did not show significant differences
between the effectiveness of different interventions for patients
with mental, behavioral or neurodevelopmental disorders. A
reason for these results may be because adherence is complex
and dynamic and requires accurate assessment of practical and
motivational barriers due to external factors associated to the
condition itself (Chapman and Horne, 2013). However, the
combination of educational + attitudinal components presented
higher SUCRA values (around 75%). These results are congruent
with previous research that showed that incorporating attitudinal
interventions, such as psychoeducation, are an effective strategy
to increase on medication adherence in patients with mental
disorders (Bond and Anderson, 2015; Hartung et al., 2017).
Attitudes and beliefs about the need to take medications can be
moderated by the condition itself, such as dependence, the feeling
of medications controlling their attitudes, or impact of medicines
on daily routines (Chakrabarti, 2016).
Rewards type interventions, interventions that provide
incentives, awards or penalties to facilitate medication adherence,
were evaluated only for one study and for one disease group
(circulatory system and metabolic diseases) with no significant
long-term effect compared to other interventions or SOC.
The intervention was focused on full payment coverage of
medications (Choudhry et al., 2011). Usually, the application of
this type of intervention requires modifications on health policies
(e.g., coverage of medications) and involves ethical concerns of
providing incentives to patients (Noordraven et al., 2017).
The limitations of this study include the categorization
of the interventions into four major groups to perform
the network meta-analyses. We acknowledge that a different
categorization system may lead to some different results.
However, this classification system, which was developed based
on three previously used classifications, allowed us to have a
clearer understanding of the interventions (Roter et al., 1998;
Demonceau et al., 2013; Sapkota et al., 2015). The use of different
classification systems for the clinical conditions may also lead
to different results. We used the standard groups proposed
by the International Classification of Diseases from the World
Health Organization. Some other important conditions groups
such as respiratory (e.g., asthma, COPD) could not be compared
because of the lack of studies reporting long-term categorical
outcomes on adherence. Results on adherence were focused
only on implementation, one of the components of the current
adherence definition proposed by ABC Project Team (Vrijens
et al., 2012) as there were not enough studies reporting initiation
or discontinuation adherence that could be analyzed. We used a
previously validated composite measure of adherence to consider
in one single model different individual measures and provide a
broad evaluation of the effectiveness of complex interventions.
The use of other measures can produce slightly different results.
CONCLUSION
Educational and technical interventions seem to bemore effective
on the long-term management of medication adherence in
patients with HIV, circulatory system and metabolic diseases,
compared to attitudinal interventions that presented a superior
effect on mental, behavioral or neurodevelopmental disorders
and musculoskeletal diseases. Multicomponent interventions are
more effective at enhancing medication adherence in three of
the four disease groups. Further analyses assessing the impact of
these interventions on clinical outcomes are needed to support
the translation of these results to daily practice. The use of
network meta-analysis was valuable for comparing interventions
aimed to improve medication adherence across chronic diseases
in long-term follow-up periods.
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